/
/
/

Genpharmasec Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Mar 2023
₹50 Cr₹55 Cr₹40 Cr₹33 Cr₹12 Cr₹14 Cr₹8 Cr₹6 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹6 Cr
₹37 L₹1 Cr₹98 L₹47 L₹70 L₹94 L₹81 L₹75 L₹57 L₹31 L₹14 L₹15 L₹6 L
₹50 Cr₹56 Cr₹41 Cr₹33 Cr₹13 Cr₹15 Cr₹9 Cr₹7 Cr₹6 Cr₹11 Cr₹7 Cr₹8 Cr₹6 Cr
₹49 Cr₹54 Cr₹42 Cr₹34 Cr₹11 Cr₹15 Cr₹8 Cr₹6 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹6 Cr
₹1 Cr₹3 Cr-₹26 L-₹80,000₹2 Cr-₹8 L₹2 Cr₹87 L₹75 L₹30 L₹16 L₹11 L₹27 L
₹40 L₹48 L₹41 L₹23 L₹12 L₹11 L₹16 L₹7 L₹10 L₹16 L₹50,000₹7 L₹6 L
₹26 L₹2 Cr-₹1 Cr-₹80 L₹1 Cr-₹44 L₹1 Cr₹50 L₹49 L₹11 L₹3 L₹4 L₹20 L
-₹17 L₹1 Cr-₹83 L-₹1 Cr₹1 Cr-₹28 L₹76 L₹70 L₹29 L₹49 L₹6 L₹60,000₹1 Cr

Share Price Live Stats

Open (₹)1.16
Volume (₹)5.15 L
High (₹)1.22
Upper Circuit1.39
Low (₹)1.12
Lower Circuit0.93
Prev Close1.16
52W High (₹)2.15
Price1.17
52W Low (₹)0.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)64.23 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.05
Price to Book1.61
Book Value1.18
EPS (TTM)-0.00
Face Value1.00
ROE (%)1.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
GENPHARMA-XNSE
LTP
1W Low
1W High
Market cap (₹)
3057.1+118.1 (4.02%)
2917.70
3141.40
4,19,654Cr
1353.1+99.6 (7.95%)
1235
1384
45,862Cr
3828.1+73.95 (1.97%)
3663.70
3900
45,287Cr
974.55-14.95 (-1.51%)
950
1004.95
44,033Cr
393.65+15.75 (4.17%)
369.55
403.55
30,661Cr
471.5+3.05 (0.65%)
464.95
483.50
15,489Cr
69.79-2.49 (-3.44%)
67.60
74.97
10,686Cr
333-5.9 (-1.74%)
332
345
7,647Cr
515.15-1.9 (-0.37%)
498.95
535
6,437Cr
111.9+1.1 (0.99%)
106.25
115.90
564Cr
1.17+0.04 (3.54%)
1.10
1.25
64Cr

Key Highlights of Genpharmasec Ltd’s P&L

In 2025-03-31, Genpharmasec Ltd reported total revenue of ₹36.78Cr, compared with ₹31.06Cr in 2024-03-31, reflecting Genpharmasec Ltd turnover.

Depreciation was ₹81.15Lakh and finance costs were ₹44.78Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹1.88Cr in 2025-03-31 as compared to ₹25.06Lakh in 2024-03-31.

Net Profit (PAT) was ₹1.25Cr in 2025-03-31 compared with ₹-₹12.57Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.02 in 2025-03-31, compared with ₹0 in 2024-03-31.